Twinbeech Capital LP Grows Position in Universal Health Services, Inc. (NYSE:UHS)

Twinbeech Capital LP lifted its stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 1,151.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 152,454 shares of the health services provider's stock after buying an additional 140,268 shares during the quarter. Twinbeech Capital LP owned approximately 0.23% of Universal Health Services worth $27,353,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of UHS. R Squared Ltd purchased a new position in shares of Universal Health Services in the fourth quarter worth $29,000. Quent Capital LLC lifted its holdings in shares of Universal Health Services by 118.3% in the fourth quarter. Quent Capital LLC now owns 179 shares of the health services provider's stock worth $32,000 after buying an additional 97 shares in the last quarter. Campbell Capital Management Inc. purchased a new position in shares of Universal Health Services in the fourth quarter worth $46,000. Huntington National Bank lifted its holdings in shares of Universal Health Services by 55.6% in the fourth quarter. Huntington National Bank now owns 280 shares of the health services provider's stock worth $50,000 after buying an additional 100 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Universal Health Services by 30.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 455 shares of the health services provider's stock worth $81,000 after buying an additional 107 shares in the last quarter. Hedge funds and other institutional investors own 86.05% of the company's stock.

Universal Health Services Trading Up 1.1%

UHS stock opened at $198.10 on Monday. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. Universal Health Services, Inc. has a twelve month low of $153.99 and a twelve month high of $243.25. The stock has a market capitalization of $12.88 billion, a price-to-earnings ratio of 13.17, a price-to-earnings-growth ratio of 0.53 and a beta of 1.29. The firm's fifty day simple moving average is $178.70 and its two-hundred day simple moving average is $185.23.

Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings data on Monday, April 28th. The health services provider reported $4.84 earnings per share for the quarter, beating analysts' consensus estimates of $4.36 by $0.48. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The business had revenue of $4.10 billion for the quarter, compared to analysts' expectations of $4.16 billion. During the same quarter in the previous year, the business posted $3.70 earnings per share. The business's revenue was up 6.7% compared to the same quarter last year. As a group, analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.

Universal Health Services Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Monday, June 2nd will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date of this dividend is Monday, June 2nd. Universal Health Services's payout ratio is presently 4.49%.

Analysts Set New Price Targets

Several brokerages recently weighed in on UHS. Baird R W cut shares of Universal Health Services from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Stephens boosted their price target on shares of Universal Health Services from $210.00 to $223.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Wells Fargo & Company reduced their price target on shares of Universal Health Services from $230.00 to $225.00 and set an "overweight" rating on the stock in a research report on Monday, March 10th. Barclays boosted their price target on shares of Universal Health Services from $249.00 to $257.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 29th. Finally, Robert W. Baird restated a "neutral" rating and issued a $224.00 price target (down previously from $274.00) on shares of Universal Health Services in a research report on Tuesday, April 15th. Nine investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, Universal Health Services presently has an average rating of "Hold" and an average target price of $224.77.

Insider Transactions at Universal Health Services

In other news, Director Maria Ruderman Singer sold 1,097 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $191.48, for a total value of $210,053.56. Following the transaction, the director now directly owns 7,884 shares in the company, valued at approximately $1,509,628.32. This represents a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 16.40% of the company's stock.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.